164 related articles for article (PubMed ID: 21826648)
1. Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells.
Hsieh YH; Margaret Juliana M; Ho KJ; Kuo HC; van der Heyde H; Elmets C; Chang PL
Int J Cancer; 2012 Jul; 131(2):322-33. PubMed ID: 21826648
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of an osteopontin-null cutaneous squamous cell carcinoma cell line.
Hsieh YH; Juliana MM; Chang PL
In Vitro Cell Dev Biol Anim; 2010 Feb; 46(2):87-91. PubMed ID: 19915934
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.
Crawford HC; Matrisian LM; Liaw L
Cancer Res; 1998 Nov; 58(22):5206-15. PubMed ID: 9823334
[TBL] [Abstract][Full Text] [Related]
4. Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.
Kamioka Y; Takakura K; Sumiyama K; Matsuda M
Cancer Sci; 2017 Feb; 108(2):226-235. PubMed ID: 27960041
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin has a protective role in prostate tumor development in mice.
Danzaki K; Kanayama M; Alcazar O; Shinohara ML
Eur J Immunol; 2016 Nov; 46(11):2669-2678. PubMed ID: 27601131
[TBL] [Abstract][Full Text] [Related]
6. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
Hayashi C; Rittling S; Hayata T; Amagasa T; Denhardt D; Ezura Y; Nakashima K; Noda M
J Cell Biochem; 2007 Jul; 101(4):979-86. PubMed ID: 17390343
[TBL] [Abstract][Full Text] [Related]
7. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin: an effector and an effect of tumor metastasis.
Shevde LA; Das S; Clark DW; Samant RS
Curr Mol Med; 2010 Feb; 10(1):71-81. PubMed ID: 20205680
[TBL] [Abstract][Full Text] [Related]
9. Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.
Peraramelli S; Zhou Q; Zhou Q; Wanko B; Zhao L; Nishimura T; Leung TH; Mizuno S; Ito M; Myles T; Stulnig TM; Morser J; Leung LLK
J Thromb Haemost; 2022 May; 20(5):1256-1270. PubMed ID: 35108449
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.
Maeda N; Ohashi T; Chagan-Yasutan H; Hattori T; Takahashi Y; Harigae H; Hasegawa H; Yamada Y; Fujii M; Maenaka K; Uede T
Retrovirology; 2015 Nov; 12():99. PubMed ID: 26597716
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
[TBL] [Abstract][Full Text] [Related]
12. Mediation of the single-walled carbon nanotubes induced pulmonary fibrogenic response by osteopontin and TGF-β1.
Khaliullin TO; Kisin ER; Murray AR; Yanamala N; Shurin MR; Gutkin DW; Fatkhutdinova LM; Kagan VE; Shvedova AA
Exp Lung Res; 2017 Oct; 43(8):311-326. PubMed ID: 29140132
[TBL] [Abstract][Full Text] [Related]
13. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
Bourassa B; Monaghan S; Rittling SR
Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
[TBL] [Abstract][Full Text] [Related]
14. Expression and inactivation of osteopontin-degrading PHEX enzyme in squamous cell carcinoma.
Neves RL; Chiarantin GMD; Nascimento FD; Pesquero JB; Nader HB; Tersariol ILS; McKee MD; Carmona AK; Barros NMT
Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):155-164. PubMed ID: 27270332
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin in the host response to Leishmania amazonensis.
Giraud E; Rouault E; Fiette L; Colle JH; Smirlis D; Melanitou E
BMC Microbiol; 2019 Feb; 19(1):32. PubMed ID: 30736736
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
Shimada Y; Watanabe G; Kawamura J; Soma T; Okabe M; Ito T; Inoue H; Kondo M; Mori Y; Tanaka E; Imamura M
Oncology; 2005; 68(2-3):285-92. PubMed ID: 16015046
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin.
Kale S; Raja R; Thorat D; Soundararajan G; Patil TV; Kundu GC
Oncogene; 2014 May; 33(18):2295-306. PubMed ID: 23728342
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin as two-sided mediator of intestinal inflammation.
Heilmann K; Hoffmann U; Witte E; Loddenkemper C; Sina C; Schreiber S; Hayford C; Holzlöhner P; Wolk K; Tchatchou E; Moos V; Zeitz M; Sabat R; Günthert U; Wittig BM
J Cell Mol Med; 2009 Jun; 13(6):1162-74. PubMed ID: 18627421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
